Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01676857 · ClinicalTrials.gov registry record
Chemokine Mechanisms in Chronic Pelvic Pain
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 147
- Enrollment target
NCT01676857: Completed study, sponsored by Northwestern University.
NCT01676857 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 147 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01676857 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 147 participants
- Enrollment target
Study Summary
The purpose of this study is to identify biomarkers that can be utilized in the diagnosis of chronic pelvic pain syndrome in men.
Primary Outcome
Cytokines/chemokines/proteins will be correlated with symptom scores from patients in a longitudinal fashion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2010-05 |
| Est. Completion | 2019-01-24 |
What the finished NCT01676857 record still lists
NCT01676857 is an observational study that tracks outcomes without assigning an intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01676857 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01676857 about?
NCT01676857 is a clinical study titled "Chemokine Mechanisms in Chronic Pelvic Pain". The purpose of this study is to identify biomarkers that can be utilized in the diagnosis of chronic pelvic pain syndrome in men.
What is the current status of trial NCT01676857?
This trial is currently completed. The enrollment target is 147 participants. The study started on 2010-05. Estimated completion is 2019-01-24.
Who is sponsoring clinical trial NCT01676857?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia